Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (19)

2024

  1. A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis

    Cancers, Vol. 16, Núm. 9

  2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246

  3. Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis

    Journal of Headache and Pain, Vol. 25, Núm. 1

  4. Telomere length and 4-year changes in cognitive function in an older Mediterranean population at high risk of cardiovascular disease

    Age and ageing, Vol. 53, Núm. 10

2023

  1. Effect of a 3-year lifestyle intervention on telomere length in participants from PREDIMED-Plus: A randomized trial

    Clinical Nutrition, Vol. 42, Núm. 9, pp. 1581-1587

  2. The coexistence of diabetic retinopathy and diabetic nephropathy is associated with worse kidney outcomes

    Clinical Kidney Journal, Vol. 16, Núm. 10, pp. 1656-1663

2022

  1. SEA 2022 Standards for Global Control of Cardiovascular Risk

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 3, pp. 130-179

  2. Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients

    Leukemia and Lymphoma, Vol. 63, Núm. 3, pp. 538-550

2021

  1. PICO questions and DELPHI methodology for the management of venous thromboembolism associated with COVID-19

    Viruses, Vol. 13, Núm. 11

2020

  1. Derivation and validation of a clinical prediction rule for thrombolysis-associated major bleeding in patients with acute pulmonary embolism: The BACS score

    European Respiratory Journal, Vol. 56, Núm. 6

  2. Risk factors for non-diabetic renal disease in diabetic patients

    Clinical Kidney Journal, Vol. 13, Núm. 3, pp. 380-388

2019

  1. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

    Orphanet Journal of Rare Diseases, Vol. 14, Núm. 1

  2. Standards for global cardiovascular risk management arteriosclerosis

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, pp. 1-43

2018

  1. Unraveling new mechanisms of renal fibrosis with potential therapeutic implications

    Hypertension

2017

  1. FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidence

    Clinical and Translational Oncology, Vol. 19, Núm. 8, pp. 997-1009

2014

  1. Longitudinal association of telomere length and obesity indices in an intervention study with a Mediterranean diet: The PREDIMED-NAVARRA trial

    International Journal of Obesity, Vol. 38, Núm. 2, pp. 177-182

2012

  1. Discovery of anticoagulant drugs: A historical perspective

    Current Drug Discovery Technologies, Vol. 9, Núm. 2, pp. 83-104

2009

  1. Matrix metalloproteinase-10 is upregulated by thrombin in endothelial cells and increased in patients with enhanced thrombin generation

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 29, Núm. 12, pp. 2109-2116

2005

  1. Effects of cryopreservation on the immunogenicity of porcine arterial allografts in early stages of transplant vasculopathy

    Cryobiology, Vol. 51, Núm. 2, pp. 130-141